$16.23-0.15 (-0.95%)
SIFCO Industries, Inc., together with its subsidiaries, produces and sells forgings and machined components primarily for the aerospace and energy, and defense and commercial space markets in the United States and internationally.
SIFCO Industries, Inc. in the Industrials sector is trading at $16.23. The stock is currently near its 52-week high of $17.57, remaining 86.1% above its 200-day moving average. Technical signals show neutral RSI of 55 and bullish MACD crossover, explaining why SIF maintains its current momentum and trend strength. The Whystock Score of 85/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
SIFCO Industries, Inc., together with its subsidiaries, produces and sells forgings and machined components primarily for the aerospace and energy, and defense and commercial space markets in the United States and internationally. The company's proce...
In the last week, the United States market has stayed flat, but it has risen by 28% over the past year with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying promising small-cap stocks can offer unique opportunities for investors seeking growth potential beyond well-known large-cap companies.
Over the last 7 days, the United States market has remained flat, yet it is up 28% over the past year with expectations for earnings to grow by 16% per annum in the coming years. In this dynamic environment, identifying undiscovered gems like Nutex Health can offer unique opportunities for investors seeking to uncover stocks with potential growth that align well with current market conditions.
SIFCO and Air Industries Group are taking different paths through aerospace demand and execution, but which setup looks more compelling right now? Let's dive in.
Meta's AI push lifts engagement, Netflix eyes revenue doubling by 2030, and Pfizer leans on new launches to offset looming patent cliffs.
Meta Platforms, Netflix and Pfizer lead fresh research as AI bets, bold 2030 goals and patent cliffs shape their outlooks.